Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: Drug screen optimization and correlation with patient response

被引：0

作者：

Smabers, L. P. ^{[1
]}

Wensink, E. ^{[1
]}

Verissimo, C. S. ^{[2
]}

Koedoot, E. ^{[2
]}

Doorn, M. ^{[2
]}

Pitsa, K-C. ^{[2
]}

Huismans, M. ^{[3
]}

Baron, C. Higuera

Valkenburg-van Iersel, L. ^{[4
]}

Brousali, A. ^{[5
]}

Overmeer, R. ^{[2
]}

Braat, M. ^{[6
]}

Elias, S. ^{[7
]}

Vries, R. ^{[2
]}

Kranenburg, O. ^{[8
]}

Koopman, M. ^{[1
]}

Boj, S. ^{[2
]}

Roodhart, J. M. L. ^{[1
]}

机构：

[1] Univ Med Ctr Utrecht, Med Oncol Dept, Utrecht, Netherlands

[2] HUB Organoids, Oncol, Utrecht, Netherlands

[3] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands

[4] Maastricht Univ, Med Oncol Dept, Med Ctr, Maastricht, Netherlands

[5] Univ Med Ctr Utrecht, Utrecht Platform Organoid Technol UPORT, Utrecht, Netherlands

[6] Univ Med Ctr Utrecht, Radiol Dept, Utrecht, Netherlands

[7] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[8] Univ Med Ctr Utrecht, Surg Oncol Dept, Utrecht, Netherlands

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1286

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2258P

引用

页码：S1161 / S1162

页数：2

共 50 条

[21] Circulating tumor DNA as a predictive biomarker for treatment response and survival in metastatic colorectal cancer
Kou, Mengying
Deng, Ying
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2024, 39 (01)
[22] NPY Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer
Janssens, Katleen
Vanhoutte, Greetje
Lybaert, Willem
Demey, Wim
Decaestecker, Jochen
Hendrickx, Koen
Kalantari, Hassan Rezaei
Zwaenepoel, Karen
Pauwels, Patrick
Fransen, Erik
de Beeck, Ken Op
Van Camp, Guy
Rolfo, Christian
Peeters, Marc
CLINICAL CANCER RESEARCH, 2023, 29 (09) : 1741 - 1750
[23] Mouse model of metastatic colorectal cancer by orthotopic transplantation of patient derived organoids
Okamoto, Takuya
Yaginuma, Katsuyuki
Nagayama, Satoshi
Yao, Ryoji
CANCER RESEARCH, 2019, 79 (13)
[24] Fluorescence lifetime imaging microscopy to assess drug response in patient-derived colorectal cancer organoids
Fong, Emma Jane
Bigger, Mathias
Kim, Seungil
Doche, Michael
Valena, Scott
Kshetri, Pratiksha
Mumenthaler, Shannon
CANCER RESEARCH, 2023, 83 (07)
[25] Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
Chen, Lifeng
Tian, Bo
Liu, Wen
Liang, Haitao
You, Yong
Liu, Weizhen
FRONTIERS IN ONCOLOGY, 2022, 12
[26] Molecular profiling of metastatic colorectal cancer patient predicts FOLFIRI treatment response
Del Rio, Maguy
Bascoul-Mollevi, Caroline
Bibeau, Frederic
Vezzio, Nadia
Gongora, Celine
Chalbos, Patrick
Boissiere-Michot, Florence
Fiess, Catherine
Kramar, Andrew
Assenat, Eric
Ychou, Marc
Martineau, Pierre
CANCER RESEARCH, 2009, 69
[27] Effects of simulated microgravity on colorectal cancer organoids growth and drug response
Kim, Soon-Chan
Kim, Min Jung
Park, Ji Won
Shin, Young-Kyoung
Jeong, Seung-Yong
Kim, Sungwan
Ku, Ja-Lok
SCIENTIFIC REPORTS, 2024, 14 (01):
[28] The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
Julien Taieb
Andreas Jung
Andrea Sartore-Bianchi
Marc Peeters
Jenny Seligmann
Aziz Zaanan
Peter Burdon
Clara Montagut
Pierre Laurent-Puig
Drugs, 2019, 79 : 1375 - 1394
[29] The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
Taieb, Julien
Jung, Andreas
Sartore-Bianchi, Andrea
Peeters, Marc
Seligmann, Jenny
Zaanan, Aziz
Burdon, Peter
Montagut, Clara
Laurent-Puig, Pierre
DRUGS, 2019, 79 (13) : 1375 - 1394
[30] Drug testing in the patient: Toward personalized cancer treatment
Coombes, R. Charles
SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (284) : 284re3

← 1 2 3 4 5 →